These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25783204)

  • 21. CE offering--introductory offer Clostridium difficile associated disease (CDAD).
    Segal P
    Pa Nurse; 2007 Jun; 62(2):18-9, 21; quiz 21-2. PubMed ID: 17668836
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
    Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
    BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.
    Cataldo MA; Granata G; Petrosillo N
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1027-1040. PubMed ID: 28980505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can improving patient hand hygiene impact Clostridium difficile infection events at an academic medical center?
    Pokrywka M; Buraczewski M; Frank D; Dixon H; Ferrelli J; Shutt K; Yassin M
    Am J Infect Control; 2017 Sep; 45(9):959-963. PubMed ID: 28863811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
    Merlo G; Graves N; Brain D; Connelly LB
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent
    Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA
    Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measures to control and prevent Clostridium difficile infection.
    Gerding DN; Muto CA; Owens RC
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S43-9. PubMed ID: 18177221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital.
    Brakovich B; Bonham E; VanBrackle L
    J Healthc Qual; 2013; 35(3):15-21. PubMed ID: 22304334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile: a reemerging pathogen.
    Calfee DP
    Geriatrics; 2008 Sep; 63(9):10-21. PubMed ID: 18763846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention.
    Louh IK; Greendyke WG; Hermann EA; Davidson KW; Falzon L; Vawdrey DK; Shaffer JA; Calfee DP; Furuya EY; Ting HH
    Infect Control Hosp Epidemiol; 2017 Apr; 38(4):476-482. PubMed ID: 28300019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence.
    Hsu J; Abad C; Dinh M; Safdar N
    Am J Gastroenterol; 2010 Nov; 105(11):2327-39; quiz 2340. PubMed ID: 20606676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C. difficile: a menace in hospitals and homes alike.
    Oriola S
    Nursing; 2006 Aug; 36(8):14-5. PubMed ID: 16888483
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.
    Barker AK; Scaria E; Safdar N; Alagoz O
    JAMA Netw Open; 2020 Aug; 3(8):e2012522. PubMed ID: 32789514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital management of Clostridium difficile infection: a review of the literature.
    Khanafer N; Voirin N; Barbut F; Kuijper E; Vanhems P
    J Hosp Infect; 2015 Jun; 90(2):91-101. PubMed ID: 25913648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    van Kleef E; Deeny SR; Jit M; Cookson B; Goldenberg SD; Edmunds WJ; Robotham JV
    Vaccine; 2016 Nov; 34(46):5562-5570. PubMed ID: 27727031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.